NCT02250001View on ClinicalTrials.gov

Asunaprevir/Daclatasvir Safety Surveillance in Japanese Patients With Chronic Hepatitis C

CompletedOBSERVATIONAL
Enrollment

2,974

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

January 20, 2017

Study Completion Date

January 20, 2017

Conditions
Chronic Hepatitis C
Trial Locations (1)

104-0033

Local Institution, Chuo-ku

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY